1 recruiting, 1 terminated, 1 unknown, 1 withdrawn. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Chronic Hypertension: new trials by email Literature Review of Chronic Hypertension trials Research Report on Chronic Hypertension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy Moms@Home, Enhanced Standard of Care - Hypertension in Pregnancy, Chronic Hypertension | Not applicable | Recruiting | University of Massachusetts, Worcester | 100 | 2025-05-16 | 2026-06-16 |
| Spironolactone in CKD Enabled by Chlorthalidone: PILOT Spironolactone, Chlorthalidone, Placebo - Renal Insufficiency, Chronic Hypertension | Phase 2 | Unknown | Indiana Institute for Medical Research | 24 | 2022-02-01 | 2023-08-14 |
| Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial labetalol (seizure prevention), MgSO4 (seizure prevention) - Preeclampsia, Pregnancy Induced Hypertension | Phase 2 / Phase 3 | Withdrawn | Baylor College of Medicine | 2015-06-01 | 2017-01-13 | |
| To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension TC-5214 - Chronic Hypertension | Phase 1 | Terminated | AstraZeneca | 80 | 2011-08-01 | 2012-10-02 |
Hypertension (3) · Hypertension, Pregnancy-Induced (2) · Eclampsia (1) · HELLP Syndrome (1) · Pre-Eclampsia (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Seizures (1)
Cardiovascular Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Urogenital Diseases (3) · Vascular Diseases (3) · Pathological Conditions, Signs and Symptoms (2) · Pregnancy Complications (2) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Signs and Symptoms (1)
Chlorthalidone (1) · Labetalol (1) · Spironolactone (1)
AstraZeneca (1) · Baylor College of Medicine (1) · Indiana Institute for Medical Research (1) · University of Massachusetts, Worcester (1)
United States (4) · Germany (1) · India (1) · United Kingdom (1)
Hans A Eriksson, MD, PhD, MBA (1) · James Ritter, MD,FRCP FFPM (1) · Lara Kovell, MD,MSc (1) · Michael A Belfort, MD, PhD (1) · Rajiv Agarwal, MD (1)
K23HL163450 (1)